obagi skintrinsiq clarifiying protocol

Generic: salicylic acid, titanium dioxide, and zinc oxide

Labeler: obagi cosmeceuticals llc
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name obagi skintrinsiq clarifiying protocol
Generic Name salicylic acid, titanium dioxide, and zinc oxide
Labeler obagi cosmeceuticals llc
Dosage Form KIT
Manufacturer
Obagi Cosmeceuticals LLC

Identifiers & Regulatory

Product NDC 62032-909
Product ID 62032-909_a9c17c57-a3af-43d6-9db3-56fb8e28894b
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M020
Listing Expiration 2026-12-31
Marketing Start 2021-08-01

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62032909
Hyphenated Format 62032-909

Supplemental Identifiers

RxCUI
251577 1235208

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name obagi skintrinsiq clarifiying protocol (source: ndc)
Generic Name salicylic acid, titanium dioxide, and zinc oxide (source: ndc)
Application Number M020 (source: ndc)

Resolved Composition

Strengths
  • 2 %
  • 6.2 %
  • 15.6 %
source: label
Packaging
  • 1 KIT in 1 BOX (62032-909-09) * 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) * 1 BOTTLE, PUMP in 1 CARTON / 48 g in 1 BOTTLE, PUMP * 1 TUBE in 1 CARTON (62032-811-09) / 85 g in 1 TUBE * 59 mL in 1 BOTTLE, PLASTIC * 60 mL in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

62032-909-09 1 KIT in 1 BOX (62032-909-09) * 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) * 1 BOTTLE, PUMP in 1 CARTON / 48 g in 1 BOTTLE, PUMP * 1 TUBE in 1 CARTON (62032-811-09) / 85 g in 1 TUBE * 59 mL in 1 BOTTLE, PLASTIC * 60 mL in 1 BOTTLE, PLASTIC

Ingredients (0)

No ingredient records.

Linked Drug Pages (1)

Obagi Skintrinsiq Clarifiying Protocol ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"spl_id": "a9c17c57-a3af-43d6-9db3-56fb8e28894b", "openfda": {"rxcui": ["251577", "1235208"], "spl_set_id": ["08ba9ea8-73fd-472b-9cc4-67df167352ec"], "manufacturer_name": ["Obagi Cosmeceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 KIT in 1 BOX (62032-909-09)  *  148 mL in 1 BOTTLE, PLASTIC (62032-612-04)  *  1 BOTTLE, PUMP in 1 CARTON / 48 g in 1 BOTTLE, PUMP *  1 TUBE in 1 CARTON (62032-811-09)  / 85 g in 1 TUBE *  59 mL in 1 BOTTLE, PLASTIC *  60 mL in 1 BOTTLE, PLASTIC", "package_ndc": "62032-909-09", "marketing_start_date": "20210801"}], "brand_name": "Obagi Skintrinsiq Clarifiying Protocol", "product_id": "62032-909_a9c17c57-a3af-43d6-9db3-56fb8e28894b", "dosage_form": "KIT", "product_ndc": "62032-909", "generic_name": "salicylic acid, titanium dioxide, and zinc oxide", "labeler_name": "Obagi Cosmeceuticals LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Obagi Skintrinsiq Clarifiying Protocol", "application_number": "M020", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210801", "listing_expiration_date": "20261231"}